195
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Medication adherence and hopelessness in male individuals with substance use disorder

ORCID Icon, ORCID Icon & ORCID Icon
Pages 218-223 | Received 29 Aug 2020, Accepted 02 Nov 2020, Published online: 09 Dec 2020
 

ABSTRACT

Objectives: This descriptive study was conducted to examine the levels of hopelessness and medication adherence in individuals diagnosed with substance use disorder.

Methods: The study was conducted at the Alcohol and Substance Use Treatment Center service of a psychiatry clinic in Turkey. The study included 100 male patients. In terms of data collection, the following were used: personal information form Beck Hopelessness Scale and Morisky Medication Adherence Scale. In the analysis of the data, number, percentage and mean, t-test, ANOVA and correlation in independent groups were used by using SPSS 22 software.

Results: This study established that the mean score of the patients from the hopelessness was 6,22 ± 4,07, and the mean score of the medication adherence was shown as 6,65 ± 1,15. This study observed a negative relationship between total hopelessness score and medication adherence score. There was a positive correlation between hopelessness total score and age. It was determined that there was a significantly negative relationship between substance use duration, age and total medicatio n adherence score.

Conclusion: The findings of the study showed that medication adherence decreased with increasing hopelessness. In addition it was determined that as age and substance use increased, hopelessness increased and adherence to treatment decreased.

Acknowledgments

The authors are grateful to all participants who agreed to participate voluntarily in this study.

Disclosure statement

The authors report no actual or potential conflicts of interest.

Additional information

Funding

No external or intramural funding was received.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.